热-pH-敏感多增强蛋白质药物的瘤透和药理学
Like Gong1, Yanshuang Qi2, Fan Zhang1
1Institute of Medical Technology, Peking University Health Science Center, Beijing, 100191, China.
这项研究引入了热-pH敏感的弹性类聚 (ELP) 来增强蛋白质药物输送. 修改后的L-asparaginase蛋白显示稳定性,细胞透性和瘤治疗效率有所改善.
科学领域:
- 生物技术是生物技术.
- 蛋白质工程是指蛋白质工程.
- 药物运输 药物运输 药物运输
背景情况:
- 蛋白质面临着诸如稳定性差,半衰期短,细胞透性有限等挑战,阻碍了它们的治疗用途.
- 现有的修改主要是提高稳定性和半衰期,忽视细胞和组织透问题.
研究的目的:
- 开发一种新型的蛋白质修饰策略,使用热-pH-敏感的弹性类似多 (ELP(HX) n) 来克服蛋白质药物限制.
- 评估ELP(HX) n融合L-阿斯巴拉金酶 (ASP) 作为智能蛋白疗法的疗效.
主要方法:
- 设计的热pH敏感的弹性类似聚 (ELP ((HX) n) 与胺 (H) 进行pH反应.
- 在基因上与ELP (HV) 60融合L-阿斯巴拉金酶 (ASP) 形成ASP-ELP (HV) 60.
- 在稳定性,半衰期和抗瘤功效方面,与原生ASP和PEGylatedASP进行了ASP-ELP (HV) 60的比较.
主要成果:
- 与ASP和PEGylated ASP相比,ASP-ELP (HV) 60表现出显著提高的稳定性和延长的半衰期.
- 修改后的蛋白质表现出更好的透到瘤细胞和组织.
- 增强的瘤细胞和组织透导致了优越的抗瘤疗效.
结论:
- ELP(HX) n融合是解决治疗应用内在蛋白质局限性的通用方法.
- 这种方法可以设计智能蛋白疗法,特别是用于有效治疗癌症.
- 对热-pH敏感的ELP修改为开发先进的基于蛋白质的药物提供了有前途的战略.
更多相关视频
07:47Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
Published on: December 13, 2015
09:51One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
Published on: September 17, 2013
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drug Distribution: Tissue Binding
For...
